Production (Stage)
Jolt Health Inc.
JOLT
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 124.08% | -37.88% | -72.60% | -81.18% | -77.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 124.08% | -37.88% | -72.60% | -81.18% | -77.01% |
| Operating Income | -124.08% | 37.88% | 72.60% | 81.18% | 77.01% |
| Income Before Tax | -49.52% | 70.13% | 78.38% | 81.13% | 78.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.52% | 70.13% | 78.38% | 81.13% | 78.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.52% | 70.13% | 78.38% | 81.13% | 78.97% |
| EBIT | -124.08% | 37.88% | 72.60% | 81.18% | 77.01% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 22.21% | 78.85% | 86.65% | 86.34% | 82.81% |
| Normalized Basic EPS | 4.47% | 76.04% | 90.11% | 89.08% | 83.54% |
| EPS Diluted | 22.21% | 78.85% | 86.65% | 86.34% | 82.81% |
| Normalized Diluted EPS | 4.47% | 76.04% | 90.11% | 89.08% | 83.54% |
| Average Basic Shares Outstanding | 90.34% | 76.98% | 66.89% | 43.75% | 42.66% |
| Average Diluted Shares Outstanding | 90.34% | 76.98% | 66.89% | 43.75% | 42.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |